Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer
Shabbir M. H. Alibhai et al.
CANCER (2021)
Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer
Shabbir M. H. Alibhai et al.
JAMA NETWORK OPEN (2021)
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer
Shabbir M. H. Alibhai et al.
CANCER (2021)
Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands
Malou C. P. Kuppen et al.
CLINICAL GENITOURINARY CANCER (2020)
Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer-5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life
X. Y. Jiang et al.
CLINICAL ONCOLOGY (2020)
Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223
Giandomenico Roviello et al.
ONCOTARGETS AND THERAPY (2019)
Relationship between patient-reported outcomes and clinical outcomes in metastatic castration-resistant prostate cancer: post hoc analysis of COU-AA-301 and COU-AA-302
D. Cella et al.
ANNALS OF ONCOLOGY (2018)
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA
Stephane Oudard et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Effects of Social Support on Health-Related Quality of Life of Patients with Metastatic Prostate Cancer
Giuseppe Colloca et al.
JOURNAL OF CANCER EDUCATION (2016)
National survey of family physicians to define functional decline in elderly patients with minor trauma
Kasim E. Abdulaziz et al.
BMC FAMILY PRACTICE (2016)
A prospective study examining elder-relevant outcomes in older adults with prostate cancer undergoing treatment with chemotherapy or abiraterone
Tharsika Manokumar et al.
JOURNAL OF GERIATRIC ONCOLOGY (2016)
Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review
S. Schmid et al.
ANNALS OF ONCOLOGY (2015)
The Diffusion of Docetaxel in Patients With Metastatic Prostate Cancer
Joseph M. Unger et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prostate Cancer in the Elderly Patient
Chunkit Fung et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effect of Depression on Diagnosis, Treatment, and Mortality of Men With Clinically Localized Prostate Cancer
Sandip M. Prasad et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
Karim Fizazi et al.
LANCET ONCOLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates
Sam Watts et al.
BMJ OPEN (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer
T. B. Dorff et al.
ANNALS OF ONCOLOGY (2013)
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
Ethan Basch et al.
LANCET ONCOLOGY (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
C. A. Bellera et al.
ANNALS OF ONCOLOGY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The burden of depression in prostate cancer
Ravishankar Jayadevappa et al.
PSYCHO-ONCOLOGY (2012)
Chemotherapy-Based Treatment for Castration-Resistant Prostate Cancer
Bostjan Seruga et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Urologists and Medical Oncologists on Treatment of Elderly Men With Stage IV Prostate Cancer
Eberechukwu Onukwugha et al.
UROLOGY (2011)
Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study
Carolina H. Y. Ling et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Heterogeneity in Rate of Decline in Grip, Hip, and Knee Strength and the Risk of All-Cause Mortality: The Women's Health and Aging Study II
Qian-Li Xue et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases
Olav Lindqvist et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2008)
American society of clinical oncology endorsement of the cancer care Ontario practice guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer
Ethan M. Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Complications arising in the final year of life in men dying from advanced prostate cancer
Richard Khafagy et al.
JOURNAL OF PALLIATIVE MEDICINE (2007)
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline
D. Andrew Loblaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Determining meaningful changes in gait speed after hip fracture
Kerstin M. Palombaro et al.
PHYSICAL THERAPY (2006)
Physiologic aspects of aging: Impact on cancer management and decision making, part II
M Sehl et al.
CANCER JOURNAL (2005)
Physiologic aspects of aging: Impact on cancer management and decision making, part I
R Sawhney et al.
CANCER JOURNAL (2005)
Analysis of treatment practices for elderly cancer patients in Ontario, Canada
C Townsley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Depression in men with prostate cancer
G Bennett et al.
ONCOLOGY NURSING FORUM (2005)
Advances in prostate cancer chemotherapy: A new era begins
KJ Pienta et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Monitoring depression treatment outcomes with the patient health questionnaire-9
B Löwe et al.
MEDICAL CARE (2004)
Is there age bias in the treatment of localized prostate carcinoma?
SMH Alibhai et al.
CANCER (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Are older French patients as willing as older American patients to undertake chemotherapy?
M Extermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The physical burden of prostate cancer
DF Penson et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier?
KWL Yee et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales
D Cella et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
The vulnerable elders survey: A tool for identifying vulnerable older people in the community
D Saliba et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)
Share Paper
